Form 6-K Kandal M Venture Ltd For: Mar 24

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of March 2026

 

Commission File Number: 001-42715

 

KANDAL M VENTURE LIMITED

 

(Registrant’s Name)

 

Padachi Village, Prek Ho Commune, Takhmao Town, Kandal Province, Kingdom of Cambodia

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒     Form 40-F ☐

 

 

 

Kandal M Venture Limited Announces Unaudited Interim 2025 Financial Results

 

References are made to the Form 6-k of Kandal M Venture Limited (the “Company”) dated March 23, 2026. The unaudited financial results for the six months ended September 30, 2025 of the Company (“Interim Results”) is furnished as Exhibit 99.1 to this Form 6-K and its management’s discussion and analysis of financial condition and results of operations is furnished as Exhibit 99.2 to this Form 6-K.

 

Exhibit Index

 

Exhibit Number		Description
99.1		Unaudited Financial Results of the Company for The Six Months Ended September 30, 2025
99.2		Management’s discussion and analysis of financial condition and results of operations

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	KANDAL M VENTURE LIMITED
Date: March 24, 2026	By:	/s/ Duncan Miao
	Name:	Duncan Miao
	Title:	Chairman of the Board of Directors

 

 

ATTACHMENTS / EXHIBITS

UNAUDITED FINANCIAL RESULTS OF THE COMPANY FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2025

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Willamette Valley Vineyards Posts Results for Q2 2026
• Anthem Blue Cross and Blue Shield Kicks Off Back-to-School Campaign in Queens
• ArkBio Announces China IND Approval for its Antiviral Drug-Fc Conjugate (AFC) Candidate AK0406 for Influenza Prophylaxis